TY - JOUR
KW - Substance-Related Disorders
KW - buprenorphine
KW - opioid-related disorders
KW - Physicians
KW - primary care
KW - Rural Health
AU - R. A. Thompson
AU - D. Johnson
AU - A. L. Kizewski
AU - L. Baier
AU - K. Coburn
AU - J. White
AU - T. Bunn
AU - E. L. Fletcher
A1 - 
AB - INTRODUCTION: Opioid and other substance use disorders (OUD/SUDs) have been and continue to be significant public health issues. The standard of care for OUD is the use of medication for opioid use disorder (MOUD) in conjunction with counseling or behavioral therapies, yet research has indicated that barriers exist for patients accessing MOUD as well as for physicians prescribing MOUD due to requirements associated with the DATA 2000 waiver. METHODS: A pilot cross-sectional survey was conducted among Kentucky physicians in order to reassess common barriers as well as to explore barriers that non-waivered providers face to becoming waivered. Barriers were compared by waiver status (waiver vs. non-waivered) as well as geographic location (rural vs. non-rural). RESULTS: Compared to waivered physicians, non-waivered physicians were significantly less likely to report positive personal beliefs related to the use of MOUD for OUD and reported significantly more barriers to treating OUD patients in the areas of physicians' practice and culture, auditing, and institutional support and resources (p < .05). The majority (69%) of all physicians indicated they would benefit from a tool kit with evidence-based clinical guidelines. CONCLUSIONS: The barriers and beliefs identified in this pilot study indicate the need for policy action at the federal level to reduce barriers and incentivize more physicians to obtain waivers to treat OUD. Further, the development of brief educational resources tailored to physicians to treat OUD patients including pregnant patients with OUD is recommended.
AD - Fletcher Group, Inc, Lexington, KY, USA.; Fletcher Group, Inc, Lexington, KY, USA.; Kentucky Injury Prevention and Research Center, University of Kentucky, Lexington, KY, USA.; Fletcher Group, Inc, Lexington, KY, USA.; Fletcher Group, Inc, Lexington, KY, USA.; Fletcher Group, Inc, Lexington, KY, USA.; Kentucky Injury Prevention and Research Center, University of Kentucky, Lexington, KY, USA.; Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health, Lexington, KY, USA.; Fletcher Group, Inc, Lexington, KY, USA.
BT - Journal of addictive diseases
C5 - Education & Workforce; Healthcare Disparities; Healthcare Policy; Opioids & Substance Use
CY - England
DO - 10.1080/10550887.2022.2035167
JF - Journal of addictive diseases
LA - eng
M1 - Journal Article
N2 - INTRODUCTION: Opioid and other substance use disorders (OUD/SUDs) have been and continue to be significant public health issues. The standard of care for OUD is the use of medication for opioid use disorder (MOUD) in conjunction with counseling or behavioral therapies, yet research has indicated that barriers exist for patients accessing MOUD as well as for physicians prescribing MOUD due to requirements associated with the DATA 2000 waiver. METHODS: A pilot cross-sectional survey was conducted among Kentucky physicians in order to reassess common barriers as well as to explore barriers that non-waivered providers face to becoming waivered. Barriers were compared by waiver status (waiver vs. non-waivered) as well as geographic location (rural vs. non-rural). RESULTS: Compared to waivered physicians, non-waivered physicians were significantly less likely to report positive personal beliefs related to the use of MOUD for OUD and reported significantly more barriers to treating OUD patients in the areas of physicians' practice and culture, auditing, and institutional support and resources (p < .05). The majority (69%) of all physicians indicated they would benefit from a tool kit with evidence-based clinical guidelines. CONCLUSIONS: The barriers and beliefs identified in this pilot study indicate the need for policy action at the federal level to reduce barriers and incentivize more physicians to obtain waivers to treat OUD. Further, the development of brief educational resources tailored to physicians to treat OUD patients including pregnant patients with OUD is recommended.
PP - England
PY - 2022
SN - 1545-0848; 1055-0887
SP - 1
EP - 9
EP - 
T1 - Assessing waivered and non-waivered physician barriers to treating patients with substance use disorders: a cross-sectional Kentucky pilot
T2 - Journal of addictive diseases
TI - Assessing waivered and non-waivered physician barriers to treating patients with substance use disorders: a cross-sectional Kentucky pilot
U1 - Education & Workforce; Healthcare Disparities; Healthcare Policy; Opioids & Substance Use
U2 - 35238283
U3 - 10.1080/10550887.2022.2035167
VO - 1545-0848; 1055-0887
Y1 - 2022
Y2 - Mar 3
ER -